Nothing Special   »   [go: up one dir, main page]

HUP0300869A2 - Eljárás klavulánsavsók előállítására - Google Patents

Eljárás klavulánsavsók előállítására

Info

Publication number
HUP0300869A2
HUP0300869A2 HU0300869A HUP0300869A HUP0300869A2 HU P0300869 A2 HUP0300869 A2 HU P0300869A2 HU 0300869 A HU0300869 A HU 0300869A HU P0300869 A HUP0300869 A HU P0300869A HU P0300869 A2 HUP0300869 A2 HU P0300869A2
Authority
HU
Hungary
Prior art keywords
clavulanic acid
medium
salt
purification
acid salt
Prior art date
Application number
HU0300869A
Other languages
English (en)
Inventor
John Mcknight
Guo Zhang
Original Assignee
Smithkline Beecham Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0300869(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0011521A external-priority patent/GB0011521D0/en
Priority claimed from GB0011519A external-priority patent/GB0011519D0/en
Application filed by Smithkline Beecham Plc. filed Critical Smithkline Beecham Plc.
Publication of HUP0300869A2 publication Critical patent/HUP0300869A2/hu
Publication of HUP0300869A3 publication Critical patent/HUP0300869A3/hu
Publication of HU228593B1 publication Critical patent/HU228593B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

A találmány klavulánsavsók tisztább állapotban történő előállításáravonatkozik, amelynek során egy klavulánsavsót egy olyan mosóközegbenmosnak, vagy egy klavulánsavsót egy olyan átkristályosítási közegbőlkristályosítanak át, vagy egy klavulánsavsót egy előállítási közegbenállítanak, amely mosóközegnek, átkristályosítási közegnek vagyelőállítási közegnek a pH-ja 6,0-nál kisebb. Ó
HU0300869A 2000-05-13 2001-05-09 Process for the purification of a salt of clavulanic acid HU228593B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0011521A GB0011521D0 (en) 2000-05-13 2000-05-13 Process
GB0011519A GB0011519D0 (en) 2000-05-13 2000-05-13 Process
PCT/GB2001/002025 WO2001087891A1 (en) 2000-05-13 2001-05-09 Process for the purification of a salt of clavulanic acid

Publications (3)

Publication Number Publication Date
HUP0300869A2 true HUP0300869A2 (hu) 2003-08-28
HUP0300869A3 HUP0300869A3 (en) 2003-10-28
HU228593B1 HU228593B1 (en) 2013-04-29

Family

ID=26244256

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300869A HU228593B1 (en) 2000-05-13 2001-05-09 Process for the purification of a salt of clavulanic acid

Country Status (24)

Country Link
US (1) US7767823B2 (hu)
EP (1) EP1284978B2 (hu)
JP (1) JP4954421B2 (hu)
KR (1) KR100827898B1 (hu)
CN (1) CN1222528C (hu)
AT (1) ATE273982T1 (hu)
AU (1) AU776184B2 (hu)
BR (1) BRPI0110774B8 (hu)
CA (1) CA2408853C (hu)
CZ (1) CZ304775B6 (hu)
DE (1) DE60105016T3 (hu)
DK (1) DK1284978T4 (hu)
ES (1) ES2225524T5 (hu)
HK (1) HK1055111A1 (hu)
HU (1) HU228593B1 (hu)
IL (2) IL152643A0 (hu)
MX (1) MXPA02011192A (hu)
NO (1) NO328528B1 (hu)
NZ (1) NZ522414A (hu)
PL (1) PL206316B1 (hu)
PT (1) PT1284978E (hu)
SI (1) SI1284978T2 (hu)
WO (1) WO2001087891A1 (hu)
ZA (1) ZA200209141B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001087891A1 (en) 2000-05-13 2001-11-22 Smithkline Beecham P.L.C. Process for the purification of a salt of clavulanic acid
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
JP2019527214A (ja) 2016-07-14 2019-09-26 アカオジェン インコーポレイテッド 細菌感染症の処置における使用のためのセフチブテンとクラブラン酸の組み合わせ
CN109305978A (zh) * 2017-07-26 2019-02-05 山东睿鹰先锋制药有限公司 一种制备克拉维酸盐的新方法
CN109535184B (zh) * 2017-09-21 2020-11-20 联邦制药(内蒙古)有限公司 一种克拉维酸叔辛胺制备克拉维酸钾的方法
CN108558909B (zh) * 2018-05-17 2019-09-17 国药集团威奇达药业有限公司 综合回收克拉维酸叔丁胺盐结晶母液中有效成分的方法
WO2021004912A1 (en) 2019-07-05 2021-01-14 Glaxosmithkline Intellectual Property (No.2) Limited Streptomyces clavuligerus

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299883A (fr) 1961-09-06 1962-07-27 Pfizer & Co C Perfectionnements apportés aux procédés pour séparer des amino-acides amphotères de leurs solutions aqueuses
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB2003863B (en) 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
DE3063683D1 (en) 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4449182A (en) * 1981-10-05 1984-05-15 Digital Equipment Corporation Interface between a pair of processors, such as host and peripheral-controlling processors in data processing systems
MX7417E (es) 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
GR1000035B (el) 1987-01-29 1990-03-12 Beecham Group Plc Κλαβουλανικο καλιο.
GB2204944B (en) 1987-05-18 1991-10-02 Frederick John Anderson Rechargeable light
DE3729338A1 (de) 1987-09-02 1989-03-23 Biotechnolog Forschung Gmbh Verfahren zur abtrennung von penicillin g aus einem fermentationsmedium durch extraktion
US5318896A (en) 1991-09-11 1994-06-07 Merck & Co., Inc. Recombinant expandase bioprocess for preparing 7-aminodesacetoxy cephalosporanic acid (7-ADCA)
CZ288721B6 (cs) 1991-10-15 2001-08-15 Dsm Gist B. V. Biologický způsob výroby kyseliny 7-aminodeacetylcefalosporanové
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9305565D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
CN1103814C (zh) 1993-07-30 2003-03-26 吉斯特·布罗卡迪斯公司 通过2－(羧乙硫基)乙酰－7－adca和3－(羧甲硫基)丙酰－7－adca有效生产7－adca的方法
AT400846B (de) 1994-02-25 1996-03-25 Fermic S A De C V Verfahren zur gewinnung und reinigung von alkalimetallsalzen der clavulansäure
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
SI9500074A (en) 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
WO1997005143A1 (fr) * 1995-07-25 1997-02-13 Asahi Kasei Kogyo Kabushiki Kaisha Nouveaux composes a base de metaux de transition du groupe 4
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
CN1238776A (zh) * 1996-11-11 1999-12-15 吉斯特-布罗卡迪斯有限公司 制备棒酸盐和酯的方法
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
WO1998042858A1 (en) 1997-03-24 1998-10-01 Cipan-Companhia Industrial Produtora De Antibióticos, S.A. Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid
PT918878E (pt) * 1997-04-22 2005-05-31 Dsm Ip Assets Bv Processo melhorado para a producao fermentativa de cefalosporina
EP1095046A1 (en) * 1998-07-16 2001-05-02 Dsm N.V. Improved process for the preparation of salts and esters of clavulanic acid
WO2001087891A1 (en) 2000-05-13 2001-11-22 Smithkline Beecham P.L.C. Process for the purification of a salt of clavulanic acid

Also Published As

Publication number Publication date
ATE273982T1 (de) 2004-09-15
US20060079676A1 (en) 2006-04-13
CN1429227A (zh) 2003-07-09
PL206316B1 (pl) 2010-07-30
BR0110774A (pt) 2003-05-13
EP1284978B2 (en) 2008-09-10
JP4954421B2 (ja) 2012-06-13
CA2408853A1 (en) 2001-11-22
DE60105016T3 (de) 2009-06-25
CA2408853C (en) 2012-01-10
IL152643A (en) 2012-12-31
PL358368A1 (en) 2004-08-09
WO2001087891A1 (en) 2001-11-22
AU776184B2 (en) 2004-09-02
AU5243201A (en) 2001-11-26
NO20025422D0 (no) 2002-11-12
EP1284978B1 (en) 2004-08-18
NZ522414A (en) 2004-05-28
BRPI0110774B1 (pt) 2015-07-07
IL152643A0 (en) 2003-06-24
EP1284978A1 (en) 2003-02-26
KR20030014222A (ko) 2003-02-15
DK1284978T3 (da) 2004-12-13
DK1284978T4 (da) 2009-01-05
PT1284978E (pt) 2004-12-31
HUP0300869A3 (en) 2003-10-28
CZ304775B6 (cs) 2014-10-15
HU228593B1 (en) 2013-04-29
MXPA02011192A (es) 2003-03-10
JP2003533529A (ja) 2003-11-11
US7767823B2 (en) 2010-08-03
DE60105016D1 (de) 2004-09-23
ZA200209141B (en) 2003-12-31
ES2225524T5 (es) 2009-03-01
DE60105016T2 (de) 2005-08-18
NO20025422L (no) 2003-01-07
HK1055111A1 (en) 2003-12-24
SI1284978T1 (en) 2005-02-28
ES2225524T3 (es) 2005-03-16
BRPI0110774B8 (pt) 2021-05-25
NO328528B1 (no) 2010-03-08
SI1284978T2 (sl) 2008-12-31
CZ20023723A3 (cs) 2003-05-14
CN1222528C (zh) 2005-10-12
KR100827898B1 (ko) 2008-05-07

Similar Documents

Publication Publication Date Title
IS7325A (is) alfa-(N-súlfonamíðó)acetamíð afleiður sem beta-amýlóíð tálmar
EA199700124A1 (ru) Производные гуанина
NO20083684L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
TWI348371B (hu)
NO994466D0 (no) Krystallinsk aminsalt av cefdinir
WO2002057252A3 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
DE60141268D1 (de) Verfahren zur Herstellung von Siliziumkarbid Einkristallen
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
HUP0204012A2 (hu) Eljárás statinvegyületek kinyerésére fermentléből
HUP0300869A2 (hu) Eljárás klavulánsavsók előállítására
NO20002589D0 (no) Bifenylamidinderivater
HUP0204069A2 (hu) Új eljárás leflunomid előállítására és a leflunomid új kristályformája és ezt tartalmazó gyógyszerkészítmény
ATE338027T1 (de) Herstellung von iminodiessigsäure-derivaten aus monoethanolamin-substraten
ATE269344T1 (de) Entfernung des natriumchlorids aus phosphonomethyliminodiessigsäure-verfahren
DE19680622D2 (de) Verfahren zum Herstellen von Siliciumcarbid-Einkristallen
ID26210A (id) Proses pemurnian turunan sefalosporin
NO20063012L (no) Fremgangsmaten for syntesen av perindopril og farmasoytisk akseptable salter derav
RS115804A (en) Pyrrolidine derivatives as oxytocin antagonists
WO2004108892A3 (en) 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
DE50000029D1 (de) Herstellung von acrylierten flüssigkristallinen Verbindungen
DE60012208D1 (de) Type 1 inhibitorkristalle als inhibitoren des natrium-protonen austauschs
RU2003110853A (ru) Способ очистки правастатина или его фармакологически приемлемой соли
NO993650L (no) Nye forbindelser med hemoregulerende effekt
UA33764A (uk) Спосіб очистки води фільтруванням
DE60123213D1 (de) Alkalimetallsalz von thiazolidin-2,4-dion-derivaten